selected scholarly activity
-
chapters
- Recent Advances in the Use of NK Cells Against Cancer. 327-348. 2021
- Recent Advances in the Use of NK Cells Against Cancer. 341-358. 2015
-
conferences
- Clinical Significance of the AJCC 8th Edition Prognostic Staging System for Triple Negative Breast Cancer (TNBC). Modern Pathology. 51-52. 2018
- Clinical Significance of the AJCC 8th Edition Prognostic Staging System for Triple Negative Breast Cancer (TNBC). Laboratory Investigation. 51-52. 2018
- Initiation of food allergy by a CD4+ T cell-intrinsic IL-4 program, controlled by OX40L (P6204). Journal of Immunology. 62.1-62.1. 2013
-
journal articles
- Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection. Current Opinion in Virology. 66:101398-101398. 2024
- Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice. npj Vaccines. 8:25. 2023
- Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. Frontiers in Immunology. 14:1286750. 2023
- Comparing Current and Next-Generation Humanized Mouse Models for Advancing HIV and HIV/Mtb Co-Infection Studies. Viruses. 14:1927-1927. 2022
- Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell. 185:896-915.e19. 2022
- COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development. The FASEB Journal. 35:e21409. 2021
- Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses. Frontiers in Immunology. 11:617516. 2020
- Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis. Frontiers in Immunology. 11:557809. 2020
- Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours. Breast Cancer Research. 19:76. 2017
- M2-polarized and tumor-associated macrophages alter NK cell phenotype and function in a contact-dependent manner. Journal of Leukocyte Biology. 101:285-295. 2017
- The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures. BMC Cancer. 16:555. 2016
- The breast tumor microenvironment alters the phenotype and function of natural killer cells. Cellular and Molecular Immunology. 13:628-639. 2016
- Innate immunosurveillance: the next frontier in the cancer immunotherapy toolbox. Translational Cancer Research. 5:S66-S70. 2016
- Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model. BMC Cancer. 15:293. 2015
- The Absence or Overexpression of IL-15 Drastically Alters Breast Cancer Metastasis via Effects on NK Cells, CD4 T Cells, and Macrophages. Journal of Immunology. 193:6184-6191. 2014
- T helper cell IL-4 drives intestinal Th2 priming to oral peanut antigen, under the control of OX40L and independent of innate-like lymphocytes. Mucosal Immunology. 7:1395-1404. 2014
- Interleukin-15 Modulates Adipose Tissue by Altering Mitochondrial Mass and Activity. PLoS ONE. 9:e114799-e114799. 2014
- Delayed but effective induction of mucosal memory immune responses against genital HSV-2 in the absence of secondary lymphoid organs. Mucosal Immunology. 6:56-68. 2013
- The Influence of Macrophages and the Tumor Microenvironment on Natural Killer Cells. Current Molecular Medicine. 13:68-79. 2013
- The Influence of Macrophages and the Tumor Microenvironment on Natural Killer Cells. Current Molecular Medicine. 13:68-79. 2012
- Critical Role of Natural Killer Cells in Lung Immunopathology During Influenza Infection in Mice. Journal of Infectious Diseases. 206:167-177. 2012
- Genital HSV-2 Infection Induces Short-Term NK Cell Memory. PLoS ONE. 7:e32821-e32821. 2012
- FimH, a TLR4 ligand, induces innate antiviral responses in the lung leading to protection against lethal influenza infection in mice. Antiviral Research. 92:346-355. 2011
- Stimulating natural killer cells to protect against cancer: recent developments. Expert Review of Clinical Immunology. 7:367-382. 2011
- Effective control of viral infections by the adaptive immune system requires assistance from innate immunity. Expert Review of Vaccines. 9:1143-1147. 2010
- ORIGINAL ARTICLE: Estradiol Limits Viral Replication Following Intravaginal Immunization Leading to Diminished Mucosal IgG Response and Non‐sterile Protection Against Genital Herpes Challenge. Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy. 63:299-309. 2010
- Susceptibility of Human Female Primary Genital Epithelial Cells to Herpes Simplex Virus, Type-2 and the Effect of TLR3 Ligand and Sex Hormones on Infection1. Biology of Reproduction. 77:1049-1059. 2007
- Differential Responses of Murine Vaginal and Uterine Epithelial Cells Prior to and Following Herpes Simplex Virus Type 2 (HSV‐2) Infection. Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy. 57:367-377. 2007
- Estradiol Regulates Susceptibility following Primary Exposure to Genital Herpes Simplex Virus Type 2, while Progesterone Induces Inflammation. Journal of Virology. 79:3107-3116. 2005
- Protection against Genital Herpes Infection in Mice Immunized under Different Hormonal Conditions Correlates with Induction of Vagina-Associated Lymphoid Tissue. Journal of Virology. 79:3117-3126. 2005
- Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression. Oncogene. 22:9151-9155. 2003
- Prolonged Exposure to Progesterone Prevents Induction of Protective Mucosal Responses following Intravaginal Immunization with Attenuated Herpes Simplex Virus Type 2. Journal of Virology. 77:9845-9851. 2003
- Pathway Pathology. American Journal of Pathology. 161:1087-1097. 2002
-
theses